| Size-selective collection of circulating tumor cells using Vortex technology E Sollier, DE Go, J Che, DR Gossett, S O'Byrne, WM Weaver, N Kummer, ... Lab on a Chip 14 (1), 63-77, 2014 | 585 | 2014 |
| Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 … AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ... Jama 319 (9), 896-905, 2018 | 309 | 2018 |
| Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist BZ Olenyuk, GJ Zhang, JM Klco, NG Nickols, WG Kaelin Jr, PB Dervan Proceedings of the National Academy of Sciences 101 (48), 16768-16773, 2004 | 290 | 2004 |
| 68Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact on salvage … J Calais, J Czernin, M Cao, AU Kishan, JV Hegde, N Shaverdian, ... Journal of Nuclear Medicine 59 (2), 230-237, 2018 | 273 | 2018 |
| Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ... JAMA network open 2 (2), e188006-e188006, 2019 | 270 | 2019 |
| Nuclear localization of pyrrole–imidazole polyamide–fluorescein conjugates in cell culture TP Best, BS Edelson, NG Nickols, PB Dervan Proceedings of the National Academy of Sciences 100 (21), 12063-12068, 2003 | 245 | 2003 |
| Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide NG Nickols, PB Dervan Proceedings of the National Academy of Sciences 104 (25), 10418-10423, 2007 | 237 | 2007 |
| A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER) LF Valle, EJ Lehrer, D Markovic, D Elashoff, R Levin-Epstein, RJ Karnes, ... European urology 80 (3), 280-292, 2021 | 189 | 2021 |
| Modulating hypoxia-inducible transcription by disrupting the HIF-1–DNA interface NG Nickols, CS Jacobs, ME Farkas, PB Dervan ACS chemical biology 2 (8), 561-571, 2007 | 165 | 2007 |
| Impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence J Calais, WP Fendler, M Eiber, J Gartmann, FI Chu, NG Nickols, RE Reiter, ... Journal of Nuclear Medicine 59 (3), 434-441, 2018 | 161 | 2018 |
| Influence of structural variation on nuclear localization of DNA‐binding polyamide‐fluorophore conjugates BS Edelson, TP Best, B Olenyuk, NG Nickols, RM Doss, S Foister, ... Nucleic acids research 32 (9), 2802-2818, 2004 | 160 | 2004 |
| Improved nuclear localization of DNA-binding polyamides NG Nickols, CS Jacobs, ME Farkas, PB Dervan Nucleic acids research 35 (2), 363-370, 2007 | 148 | 2007 |
| Antitumor activity of a pyrrole-imidazole polyamide F Yang, NG Nickols, BC Li, GK Marinov, JW Said, PB Dervan Proceedings of the National Academy of Sciences 110 (5), 1863-1868, 2013 | 142 | 2013 |
| Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial AU Kishan, TM Ma, JM Lamb, M Casado, H Wilhalme, DA Low, K Sheng, ... JAMA oncology 9 (3), 365-373, 2023 | 130 | 2023 |
| Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression KA Muzikar, NG Nickols, PB Dervan Proceedings of the National Academy of Sciences 106 (39), 16598-16603, 2009 | 129 | 2009 |
| Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings: a prospective single-center study I Sonni, M Eiber, WP Fendler, RM Alano, SS Vangala, AU Kishan, ... Journal of Nuclear Medicine 61 (8), 1153-1160, 2020 | 114 | 2020 |
| Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT] J Calais, J Czernin, WP Fendler, D Elashoff, NG Nickols BMC cancer 19, 1-11, 2019 | 113 | 2019 |
| Clinical outcomes for patients with Gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis AU Kishan, T Shaikh, PC Wang, RE Reiter, J Said, G Raghavan, ... European urology 71 (5), 766-773, 2017 | 108 | 2017 |
| MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer NG Nickols, R Nazarian, SG Zhao, V Tan, V Uzunangelov, Z Xia, ... Prostate cancer and prostatic diseases 22 (4), 531-538, 2019 | 92 | 2019 |
| Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis AU Kishan, Y Sun, H Hartman, TM Pisansky, M Bolla, A Neven, A Steigler, ... The lancet oncology 23 (2), 304-316, 2022 | 89 | 2022 |
